Sort   by:  
 Page size 
TranscriptomicsComparison between cell lines from 9 different cancer tissue (NCI-60) (Affymetrix U133 Plus 2.0)
Comparison between cell lines from 9 different cancer tissue of origin types (Breast, Central Nervous System, Colon, Leukemia, Melanoma, Non-Small Cell Lung, Ovarian, Prostate, Renal) from NCI-60 panel. Cell lines from 9 different cancer tissue of origin types
ORGANISM(S): Homo sapiens 
2011-09-28 | E-GEOD-32474 | biostudies-arrayexpress
TranscriptomicsMicroRNA profiling of the NCI-60 panel of human cancer cell lines
Advances in the understanding of cancer cell biology and response to drug treatment have benefited from new molecular technologies and methods for integrating information from multiple sources. The NCI-60, a panel of 60 diverse human cancer cell lines, has been used by the National Cancer Institute...
ORGANISM(S): Homo sapiens 
2007-04-02 | E-MEXP-1029 | biostudies-arrayexpress
TranscriptomicsMicroRNA profiling by array of NCI-60 human cancer cell-lines
Affymetrix GeneChip miRNA arrays were used to profile the expression of microRNAs in cells of sixty NCI-60 cancer cell-lines
ORGANISM(S): Homo sapiens 
2011-01-10 | E-MTAB-327 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human NCI-60 Cancer Cell Line
NCI-60 cancer cell lines were profiled with their genome-wide gene expression patterns using Affymetrix HG-U133A chips. Experiment Overall Design: Total RNA sample of each of the NCI-60 cell lines was obtained before the treatment of any anticancer compound.
ORGANISM(S): Homo sapiens 
2009-09-15 | E-GEOD-5846 | biostudies-arrayexpress
ProteomicsDDA files of human cancer cells for the NCI-60 SWATH project PXD003539
This is the raw files for the DDA library used for intepreting the NCI-60 SWATH project PXD003539
ORGANISM(S): Homo sapiens (Human) 
2019-10-21 | PXD009597 | Pride
Cancer  shotgun  swath library  nci-60 
TranscriptomicsPermissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
Oncolytic viral therapy represents an alternative therapeutic strategy for the treatment of cancer. This therapy relies on efficient replication of virus in tumor cells in vivo with minimal or no replication in normal tissues. We recently described GLV-1h68 as a modified Vaccinia Virus (VACV) constr...
ORGANISM(S): Homo sapiens 
2012-03-24 | E-GEOD-28472 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human cell lines from 9 different cancer tissue (NCI-60) (U133 platform)
Comparison between cell lines from 9 different cancer tissue of origin types (Breast, Central Nervous System, Colon, Leukemia, Melanoma, Non-Small Cell Lung, Ovarian, Prostate, Renal) from NCI-60 panel Experiment Overall Design: cell lines from 9 different cancer tissue of origin types
ORGANISM(S): Homo sapiens 
2008-06-14 | E-GEOD-5720 | biostudies-arrayexpress
TranscriptomicsNCI60 Expression Profiling using the Agilent Whole Human Genome Oligo Microarray
We present here a new expression profiling study of the 60 cell lines of the National Cancer Institute (NCI) Developmental Therapeutics program (DTP) drug screen (NCI-60) using the 41,000-probe Agilent Whole Human Genome Oligo Microarray. The expression levels of ∼21,000 genes were measured. The pr...
ORGANISM(S): Homo sapiens 
2010-07-31 | E-GEOD-22821 | biostudies-arrayexpress
ProteomicsGlobal Proteome Analysis of the NCI-60 Cell Line Panel
The NCI-60 cell line collection is a very widely used panel for the study of cellular mechanisms of cancer in general and in vitro drug action in particular. It is a model system for the tissue types and genetic diversity of human cancers and has been extensively molecularly characterized. Here, we ...
ORGANISM(S): Homo sapiens (Human) 
2017-03-31 | PXD005940 | Pride
Lc-ms/ms Nci60 Dtp 
ProteomicsGlobal Proteome Analysis of the NCI-60 Cell Line Panel, part 3
The NCI-60 cell line collection is a very widely used panel for the study of cellular mechanisms of cancer in general and in vitro drug action in particular. It is a model system for the tissue types and genetic diversity of human cancers and has been extensively molecularly characterized. Here, we ...
ORGANISM(S): Homo sapiens (Human) 
2017-09-25 | PXD005946 | Pride
Lc-ms/ms Nci60 Dtp 
Sort   by:  
 Page size